Attached files

file filename
EX-10.1 - EXCLUSIVE LICENSE AGREEMENT - ID Perfumes, Inc.aena_ex101.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
FORM 8-K/A-2
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):   September 25, 2013

ID PERFUMES, INC.
(Exact name of registrant as specified in its charter)

Nevada
(State or other jurisdiction
of incorporation)
0-52675
(Commission File
Number)
20-8837626
(IRS Employer
Identification No.)

1250 E. Hallandale Beach Blvd
Suite 402
Hallandale, FL  33009
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (954) 454-9978
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act.

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act.

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.



 
 
 
 
 
CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS
 
This report contains forward-looking statements. The forward-looking statements are contained principally in the sections entitled These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “would” and similar expressions intended to identify forward-looking statements. Forward-looking statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements.

Also, forward-looking statements represent our estimates and assumptions only as of the date of this report. You should read this report and the documents that we reference and filed as exhibits to the report completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.
 
Section 1- Registrant’s Business and Operations

Item 1.01 Entry into a Material Definitive Agreement

On September 25, 2013  we entered into an exclusive license agreement (the “License Agreement”)  with Kendall Jenner Inc. (the “Licensor”).  The terms and conditions of the License Agreement were disclosed in the Company’s Form 8-k filed with the Securities and Exchange Commission on October 1, 2013.

We previously requested confidential treatment for certain portions of the License Agreement and that information was redacted from the public filing.  The Company has withdrawn its request for Confidentiality Treatment.

 A copy of the License Agreement with no redacted information is attached hereto as Exhibit 10.1.  
 
Section 9- Financial Statements and Exhibits

Exhibits
 
Exhibit No.   Description
     
10.1   Exclusive License Agreement executed between ID Perfumes, Inc. and Kendall Jenner, Inc.

 
 
2

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  ID PERFUMES, INC  
       
Date:  February 20, 2014  
By:
/s/ Ilia Lekach  
    Ilia Lekach  
   
Chief Executive Officer
 
       

 
 
3